UDC

[576.385:612.1]+612.67

DOI

10.37482/2687-1491-Z043

Authors

Evgeniya A. Sladkova* ORCID: 0000-0003-3072-2402
*Belgorod State National Research University
(Belgorod, Russian Federation)
Corresponding author: Evgeniya Sladkova, address: ul. Pobedy 85, korp. 20, aud. 2-5, Belgorod, 308015, Russian Federation; e-mail: sladkova@bsu.edu.ru

Abstract

Adenosine triphosphate (ATP) molecules and nucleotide derivatives contribute to a wide range of cellular reactions through the activation of A2 and P2 purinergic receptors located on the cell surface. Almost any type of cells expresses such receptors, including red blood cells and white blood cells. The study of purinergic transmission of signals mediating calcium mobilization, actin polymerization, chemotaxis, release of mediators, tissue oxygenation, cell maturation, cytotoxicity, cell death and cell– cell interactions in dynamics at different stages of ontogenesis is an important issue in biology and medicine today. This paper aimed to explore the biophysical properties of blood cells during the activation of the purinergic signalling system in middle-aged people and older adults. To activate the elements of the purinergic signalling system, an in vitro model of mechanical stress was used. Blood samples were analysed using the methods of atomic force microscopy, namely, force spectroscopy and the Kelvin probe. When the purinergic signalling system is activated, an increase in ATP blood concentration is identified in the blood of both middle-aged people and older adults. In the blood of older adults, a smaller amount of ATP was recorded compared with the blood of middle-aged people, which can be due to changes in the expression of purinoreceptors on the surface of red blood cells at ageing. Erythrocytes and granulocytes in older adults are characterized by increased surface stiffness and potential upon activation of the purinergic signalling system, compared with cells of middle-aged people. In response to mechanical stress, lymphocyte membrane stiffness in older adults increases more significantly than in middle-aged people. Thus, the results indicate an important role of the ATP molecule and its derivatives in the regulation of functioning of blood cells through binding to receptors of the P2 family. Research on the changes in the biophysical properties of red blood cells and white blood cells at activation of the purinergic signalling system will allow us to identify new effects of purine compounds on intercellular interaction during ageing.
For citation: Sladkova E.A. Influence of the Purinergic Signalling System on the Properties of Human Blood Cells at Ageing. Journal of Medical and Biological Research, 2021, vol. 9, no. 1, pp. 51–57. DOI: 10.37482/2687-1491-Z043

Keywords

purinergic signalling system, red blood cells, white blood cells, surface potential, Youngʼs modulus, ATP, middle age, old age

References

1. Olivieri A., Pala M., Gandini F., Hooshiar Kashani B., Perego U.A., Woodward S.R., Grugni V., Battaglia V., Semino O., Achilli A., Richards M.B., Torroni A. Mitogenomes from Two Uncommon Haplogroups Mark Late Glacial/ Postglacial Expansions from the Near East and Neolithic Dispersals Within Europe. PLoS One, 2013, vol. 8, no. 7. Art. no. e70492. DOI: 10.1371/journal.pone.0070492
2. Uzikova E.V., Miloradov M.Yu., Levin V.N., Bulaeva S.V., Muravʼev A.V., Chirkova Zh.V. Issledovanie izmeneniya agregatsii eritrotsitov pri inkubatsii s zameshchennymi 4-gidroksi-6,7-ditsiano-1,4-benzoksazin-3-onami [Research of Change of Red Blood Cell Aggregation During Incubation with 4-Hydroxy-6,7-Dicyanobenzoxazine-3-Ones]. Yaroslavskiy pedagogicheskiy vestnik, 2011, vol. 3, no. 4, pp. 108–112.
3. Burnstock G. Purinergic Signalling. Br. J. Pharmacol., 2006, vol. 147, suppl. 1, pp. S172–S181. DOI: 10.1038/sj.bjp.0706429
4. Bagatini M.D., Dos Santos A.A., Cardoso A.M., Mânica A., Reschke C.R., Carvalho F.B. The Impact of Purinergic System Enzymes on Noncommunicable, Neurological, and Degenerative Diseases. J. Immunol. Res., 2018, vol. 2018. Art. no. 4892473. DOI: 10.1155/2018/4892473
5. Cieślak M., Czarnecka J., Roszek K. The Roles of Purinergic Signaling in Psychiatric Disorders. Acta Biochim. Pol., 2016, vol. 63, no. 1, pp. 1–9. DOI: 10.18388/abp.2015_1004
6. Jimenez-Pacheco A., Diaz-Hernandez M., Arribas-Blázquez M., Sanz-Rodriguez A., Olivos-Oré L.A., Artalejo A.R., Alves M., Letavic M., Miras-Portugal M.T., Conroy R.M., Delanty N., Farrell M.A., OʼBrien D.F., Bhattacharya A., Engel T., Henshall D.C. Transient P2X7 Receptor Antagonism Produces Lasting Reductions in Spontaneous Seizures and Gliosis in Experimental Temporal Lobe Epilepsy. J. Neurosci., 2016, vol. 36, no. 22, pp. 5920–5932. DOI: 10.1523/JNEUROSCI.4009-15.2016
7. Oonishi T., Sakashita K., Uyesaka N. Regulation of Red Blood Cell Filterability by Ca2+ Influx and cAMP-Mediated Signaling Pathways. Am. J. Physiol., 1997, vol. 273, no. 6, pp. C1828–C1834. DOI: 10.1152/ajpcell.1997.273.6.C1828
8. Skorkina M.Yu., Fedorova M.Z., Zabinyakov N.A., Sladkova E.A. Method for Determining Blood Cell Elasticity. Patent RF no. 2466401, 2011 (in Russ.).
9. Sladkova E.A., Skorkina M.Y. Estimation of Surface Potential of Lymphocytes from Patients with Leukemia Using Kelvin Probe Mode. Biophysics, 2014, vol. 59, no. 2, pp. 254–256.
10. Baroja-Mazo A., Barberà-Cremades M., Pelegrín P. The Participation of Plasma Membrane Hemichannels to Purinergic Signaling. Biochim. Biophys. Acta, 2013, vol. 1828, no. 1, pp. 79–93. DOI: 10.1016/j.bbamem.2012.01.002
11. Kovalenko S.S., Yusipovich A.I., Parshina E.Y., Maksimov G.V. Role of Purinergic Receptors of Erythrocytes in the Regulation of Conformation and Oxygen- and NO-Transporting Capacity of Hemoglobin. Bull. Exp. Biol. Med., 2015, vol. 159, no. 2, pp. 213–216.
12. Graf M., Prins R.M., Merchant R.E. IL-6 Secretion by a Rat T9 Glioma Clone Induces a Neutrophil-Dependent Antitumor Response with Resultant Cellular, Antiglioma Immunity. J. Immunol., 2001, vol. 166, no. 1, pp. 121–129. DOI: 10.4049/jimmunol.166.1.121
13. Burnstock G. Purinergic Signalling: Pathophysiology and Therapeutic Potential. Keio J. Med., 2013, vol. 62, no. 3, pp. 63–73. DOI: 10.2302/kjm.2013-0003-re
14. Jarvis M.F. Characterization of P1 (Adenosine) Purinoceptors. Curr. Protocols Pharmacol., 2013, vol. 62, no. 1, pp. 1.9.1–1.9.16. DOI: 10.1002/0471141755.ph0109s62
15. Chen Y., Yao Y., Sumi Y., Li A., To U.K., Elkhal A., Inoue Y., Woehrle T., Zhang Q., Hauser C., Junger W.G. Purinergic Signaling: A Fundamental Mechanism in Neutrophil Activation. Sci. Signal., 2010, vol. 3, no. 125. Art. no. ra45. DOI: 10.1126/scisignal.2000549
16. North R.A. P2X Receptors. Philos. Trans. R. Soc. Lond. B. Biol. Sci., 2016, vol. 371, no. 1700. Art. no. 20150427. DOI: 10.1098/rstb.2015.0427